Search Results - "Suzanne Hol"

Competition for Light between Toxic and Nontoxic Strains of the Harmful Cyanobacterium Microcystis by Kardinaal, W. Edwin A, Tonk, Linda, Janse, Ingmar, Hol, Suzanne, Slot, Pieter, Huisman, Jef, Visser, Petra M

“…The cyanobacterium Microcystis can produce microcystins, a family of toxins that are of major concern in water management. In several lakes, the average…”
Get full text

Competition for nutrients and light: stable coexistence, alternative stable states, or competitive exclusion? by Passarge, Jutta, Hol, Suzanne, Escher, Marieke, Huisman, Jef

“…Competition theory has put forward three contrasting hypotheses: Competition for nutrients and light may lead to (i) stable coexistence of species, (ii)…”
Get full text

Competition and Facilitation between Unicellular Nitrogen-Fixing Cyanobacteria and Non-Nitrogen-Fixing Phytoplankton Species by Nona S. R. Agawin, Sophie Rabouille, Marcel J. W. Veldhuis, Lidewij Servatius, Suzanne Hol, Harriët M. J. van Overzee, Huisman, Jef

“…Recent discoveries show that small unicellular nitrogen-fixing cyanobacteria are more widespread than previously thought and can make major contributions to…”
Get full text

N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda by te Velthuis, Henk, Knop, Ingrid, Stam, Peter, van den Broek, Monic, Bos, Hannie Klaasse, Hol, Suzanne, Teunissen, Elisa, Fischedick, Karin Schulte, Althaus, Harald, Schmidt, Brigitta, Wagner, Carola, Melsert, Roel

“…High serum concentrations of monoclonal free light chain (FLC) kappa or lambda are markers of plasma cell dyscrasia. We developed new, latex-enhanced, specific…”
Get more information

Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis by Hoedemakers, Rein M J, Pruijt, Johannes F M, Hol, Suzanne, Teunissen, Elisa, Martens, Henk, Stam, Peter, Melsert, Roel, Te Velthuis, Henk

“…New monoclonal antibody-based assays for serum-free light chains (FLC) have become available. In a clinical study with 541 patients, the new N Latex FLC assays…”
Get more information